Skip to contentE
Escalon Medical Corp
E
ESMCEscalon Medical Corp Q3 2019 · 10-Q
Revenue$2.67M$2.67M+1.3% vs Q3 2018 Net Income$22.21K$22.21KN/M vs Q3 2018 EPS Diluted$0.00$0.00N/M vs Q3 2018 Operating Income$22,185N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$122,663N/M Margins · derivedOperating margin0.8%+4.3 pt vs Q3 2018
Net margin0.8%+5.4 pt vs Q3 2018
ended Mar 31, 2019 · filed May 14, 2019 · 44 d after period end